Practicing beekeeping for a minimum of two hours per week can enhance heart health and raise antiviral immunity. Beekeeping ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Say goodbye to body acne with the Blu Atlas Natural Exfoliating Bar Soap that’s a game-changer for men’s skin — details!

CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how ...

Wisconsin is among 10 states to report human cases of the H5N1 virus so far, with more than half reported in California.

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

Some in the medical community say that antiviral treatments are underutilized and could help more people recover from ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load.

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...